Tumor Microcirculation

Room A 104-105      16:00 - 18:00                                     Chairs: David L. Buckley and Nina A. Mayr

16:00      741.    Feasibility of Dynamic Susceptibility-Weighted Perfusion MRI at 3T Using a Standard Head Coil and 8-Channel Phased-Array Coil with and Without SENSE Reconstruction

Janine Marie Lupo1, Michael C. Lee1, Eric T. Han2, Soonmee Cha1, Susan M. Chang1, Mitchel S. Berger1,

Sarah J. Nelson1

1University of California, San Francisco, California, USA; 2Applied Science Lab-West, Menlo Park, California, USA

16:12      742.    A Novel Method of Model-Based Rigid Registration for Dynamic Contrast Enhanced MRI Studies.  - not available

Giovanni A. Buonaccorsi1, Caleb Roberts1, Sue Cheung1, Yvon Watson1, Geoff JM Parker1

1University of Manchester, Manchester, UK

16:24      743.    Deconvolution-Based Dynamic Contrast Enhanced MR Imaging of Breast Tumors for Perfusion Quantification: A Feasibility Study

Smitha Makkat1, Steven Sourbron1, Martine Dujardin1, Peter Van Schuerbeek1, Robert Luypaert1, Tadeusz Stadnik1

1Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium

16:36      744.    Analysis of Metabolic Levels in Regions of Abnormal Perfusion in High-Grade Glioma Patients

Janine Marie Lupo1, Soonmee Cha1, Susan M. Chang1, Mitchel S. Berger1, Sarah J. Nelson1

1University of California, San Francisco, California, USA

16:48      745.    Dynamic Contrast Enhanced MRI (DCE-MRI) for Predicting Clinical Response to Bevacizumab and Chemotherapy in Previously Untreated Inflammatory Breast Cancer: A Comparison of Analytic Methods

Arpi Doshi1, David Michael Thomasson1, Reyes Maria Garcia-Eulate1, Suparna Bonthala Wedam1, Betty J. Wise1, Sandeep N. Gupta2, Jianhua Yao1, Seth M. Steinberg1, David J. Liewehr1, Peter L. Choyke1, Sandra M. Swain1

1National Institutes of Health, Bethesda, Maryland, USA; 2GE Healthcare Technologies, Baltimore, Maryland, USA

17:00      746.    Transfer Constant and Plasma Volume Fraction in Dynamic Contrast Enhanced Magnetic Resonance Imaging: Different Dependencies on Tumor Model, Size, and Antivascular Treatment

Thomas Nielsen1, Ross J. Maxwell2, Hans Stødkilde-Jørgensen1, Leif Østergaard1, Michael R. Horsman1

1Aarhus University Hospital, Aarhus, Denmark; 2Gray Cancer Institute, Northwood, UK

17:12      747.    Growth Factors and Integrins Associated with Contrast-Enhancing Regions of GBM  - not available

Samira Guccione1, Yi-Shan Yang1, Yen Lin Chia1, Yingyung Wang1, Michael Lim1, Ron Homer1, Griff Harsh1,

Scott Atlas1, Mark Bednarski1

1Stanford University, Stanford, California, USA

17:24      748.    Changes in the Transfer Constant of a Macromolecular MR Contrast Agent After Dexamethasone Administration in 9L Rat Cerebral Tumor  - not available

James Russell Ewing1, Stephen Russell Brown1, Jamie Russell Churchman1, Swayamprava Russell Panda1,

Ramesh Russell Paudyal1, Joseph Russell Fenstermacher1

1Henry Ford Health Systems, Detroit, Michigan, USA

17:36      749.    Dynamic Contrast-Enhanced MRI for Quantifying VEGF-Enhanced Neovascularization in Tissue-Engineered Bladder Constructs

Hai-Ling Margaret Cheng1,2, Jun Chen1, Paul S. Babyn1, Walid A. Farhat1

1The Hospital for Sick Children, Toronto, Ontario, Canada; 2University of Toronto, Toronto, Ontario, Canada

17:48      750.    Transcapillary Transport and Interstitial Fluid Pressure in Tumors; Monitoring by DCE-MRI Using Instantaneous and Slow Infusion.

Yaron Hassid1, Raanan Margalit1, Dalia Seger1, Maya Dadiani1, Hadassa Degani1

1Weizmann Institute Of Science, Rehovot, Israel